Indication
Psoriatic Arthritis
The Psoriatic Arthritis pipeline: 42 tracked drugs, 34 approved for this indication.
34 approved / phase 45 Phase 31 Phase 22 Phase 1
Compare the share prices of listed companies in Psoriatic Arthritis →
Total attributable cost
$27.1B
$29,742/patient
Drug spend
$12.9B
$14,174/patient
48% of total cost is drugs
All severities · US